Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system.
Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More
Pharma
Healthcare & Life Science M&A Activity Plummets 1H’22
What You Should Know:
- The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%.
- Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector.
Key Trends and
Read More
VC General Catalyst Closes $675M Health Assurance Fund II
What You Should Know:
- Early-stage venture capital firm General Catalyst closes $670 million Health Assurance Fund II.
- The new fund comes on the heels of the Health Assurance Fund I closed in April of 2021 at $600M. To date, General Catalyst has invested $1.7B in companies aligned with the health assurance thesis.
Health Assurance Fund II Investment Thesis
This new fund will allow us to continue to accelerate General Catalyst’s work on building a value-oriented system and focus
Read More
Dear Digital Healthcare: Let’s Do Better
Digital transformation has increased healthcare access, but quality and consistency are lagging behind. A human touch – and some innovative thinking – can get us where we need to be.
We weren’t prepared. But can you blame us?
The healthcare industry has gone digital faster than anyone could’ve expected. Digital health options like telemedicine and online pharmacies existed before the pandemic. At some point, they would’ve naturally risen to prominence. COVID-19 forced us to stuff a
Read More
Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video
Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media.
Pharma advertisers spend billions on traditional TV advertising, but as streaming services began to experience explosive growth early in the pandemic, advertising strategies had to adapt. TV-centric advertisers relied on (and still rely on) dayparting (scheduling ads during certain times of the
Read More
Innovaccer Launches Connected Digital Health Solution for Biopharma & Medtech
What You Should Know:
- Today Innovaccer, the Health Cloud company, announced its Connected Digital Health solution, a new way for life sciences companies to rapidly deliver next-generation digital apps that surround therapeutics and devices with highly engaging patient experiences, improve clinical outcomes, and generate valuable real-world evidence (RWE).
- The new solution will allow life sciences companies to realize the promise of digital health with holistic, “around-the-brand”
Read More
Analysis: Is Oracle Cerner Planning to Build A National EHR?
Earlier this month Oracle closed its $28.3B acquisition of Cerner and shortly after Oracle founder and CTO, Larry Ellison, outlined Oracle’s vision for Healthcare IT post-acquisition. The key elements of this vision included:
- Developing a solution for a national EHR database.
- Leveraging this solution, and similar smaller-scale connected EHR initiatives, to provide life science, pharma and other users with a rich environment for research, clinical trials and drug
Read More
Wavemaker Three-Sixty Health Closes $64M Fund to Invest in Early-Stage Startups
What You Should Know:
- Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, recently announced its Fund II news, closing at $64M, surpassing its first fund nearly four times over.
- The goal for Fund II is to invest into 40-50 early-stage companies, with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health,
Read More
H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data
What You Should Know:
- H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.
- The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More
Insilico Medicine Raises $60M, Launches AI-powered Drug Discovery Robotics Laboratory
What You Should Know:
- Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
- Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
